company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2009.0,Q2,2009-03-29,2009-06-27,2010-08-03 16:42:50+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,308159000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2009.0,Q2,2009-03-29,2009-06-27,2010-08-03 16:42:50+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,308159000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2009.0,Q2,2009-03-29,2009-06-27,2010-08-03 16:42:50+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,193696000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2009.0,Q2,2009-03-29,2009-06-27,2010-08-03 16:42:50+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,193696000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2009.0,Q2,2009-03-29,2009-06-27,2010-08-03 16:42:50+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,114463000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2009.0,Q2,2009-03-29,2009-06-27,2010-08-03 16:42:50+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,56582000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2009.0,Q2,2009-03-29,2009-06-27,2010-08-03 16:42:50+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,7219000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2009.0,Q2,2009-03-29,2009-06-27,2010-08-03 16:42:50+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,63801000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2009.0,Q2,2009-03-29,2009-06-27,2010-08-03 16:42:50+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,50662000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2009.0,Q2,2009-03-29,2009-06-27,2010-08-03 16:42:50+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,5351000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2009.0,Q2,2009-03-29,2009-06-27,2010-08-03 16:42:50+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,409000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2009.0,Q2,2009-03-29,2009-06-27,2010-08-03 16:42:50+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1565000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2009.0,Q2,2009-03-29,2009-06-27,2010-08-03 16:42:50+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3377000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2009.0,Q2,2009-03-29,2009-06-27,2010-08-03 16:42:50+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,47285000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2009.0,Q2,2009-03-29,2009-06-27,2010-08-03 16:42:50+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,13630000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2009.0,Q2,2009-03-29,2009-06-27,2010-08-03 16:42:50+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,33655000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2009.0,Q2,2009-03-29,2009-06-27,2010-08-03 16:42:50+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,33655000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2009.0,Q2,2009-03-29,2009-06-27,2010-08-03 16:42:50+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-499000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2009.0,Q2,2009-03-29,2009-06-27,2010-08-03 16:42:50+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,34154000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2009.0,Q2,2009-03-29,2009-06-27,2010-08-03 16:42:50+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,64400000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2009.0,Q2,2009-03-29,2009-06-27,2010-08-03 16:42:50+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.53
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2009.0,Q2,2009-03-29,2009-06-27,2010-08-03 16:42:50+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,65700000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2009.0,Q2,2009-03-29,2009-06-27,2010-08-03 16:42:50+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.52
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2009.0,Q2,2009-03-29,2009-06-27,2010-08-03 16:42:50+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,64400000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2009.0,Q2,2009-03-29,2009-06-27,2010-08-03 16:42:50+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.53
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2009.0,Q3,2009-06-28,2009-09-26,2010-11-04 14:58:02+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,297485000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2009.0,Q3,2009-06-28,2009-09-26,2010-11-04 14:58:02+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,297485000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2009.0,Q3,2009-06-28,2009-09-26,2010-11-04 14:58:02+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,190921000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2009.0,Q3,2009-06-28,2009-09-26,2010-11-04 14:58:02+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,190921000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2009.0,Q3,2009-06-28,2009-09-26,2010-11-04 14:58:02+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,106564000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2009.0,Q3,2009-06-28,2009-09-26,2010-11-04 14:58:02+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,54129000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2009.0,Q3,2009-06-28,2009-09-26,2010-11-04 14:58:02+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,7988000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2009.0,Q3,2009-06-28,2009-09-26,2010-11-04 14:58:02+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,62117000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2009.0,Q3,2009-06-28,2009-09-26,2010-11-04 14:58:02+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,44447000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2009.0,Q3,2009-06-28,2009-09-26,2010-11-04 14:58:02+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,5572000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2009.0,Q3,2009-06-28,2009-09-26,2010-11-04 14:58:02+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,284000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2009.0,Q3,2009-06-28,2009-09-26,2010-11-04 14:58:02+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1281000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2009.0,Q3,2009-06-28,2009-09-26,2010-11-04 14:58:02+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4007000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2009.0,Q3,2009-06-28,2009-09-26,2010-11-04 14:58:02+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,40440000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2009.0,Q3,2009-06-28,2009-09-26,2010-11-04 14:58:02+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,6900000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2009.0,Q3,2009-06-28,2009-09-26,2010-11-04 14:58:02+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,33540000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2009.0,Q3,2009-06-28,2009-09-26,2010-11-04 14:58:02+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,3451000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2009.0,Q3,2009-06-28,2009-09-26,2010-11-04 14:58:02+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,36991000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2009.0,Q3,2009-06-28,2009-09-26,2010-11-04 14:58:02+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-322000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2009.0,Q3,2009-06-28,2009-09-26,2010-11-04 14:58:02+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,37313000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2009.0,Q3,2009-06-28,2009-09-26,2010-11-04 14:58:02+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,65500000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2009.0,Q3,2009-06-28,2009-09-26,2010-11-04 14:58:02+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.57
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2009.0,Q3,2009-06-28,2009-09-26,2010-11-04 14:58:02+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,65500000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2009.0,Q3,2009-06-28,2009-09-26,2010-11-04 14:58:02+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.57
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2009.0,Q3,2009-06-28,2009-09-26,2010-11-04 14:58:02+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,65500000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2009.0,Q3,2009-06-28,2009-09-26,2010-11-04 14:58:02+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.57
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2010.0,Q1,2009-12-27,2010-03-27,2011-05-04 15:42:07+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,292287000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2010.0,Q1,2009-12-27,2010-03-27,2011-05-04 15:42:07+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,292287000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2010.0,Q1,2009-12-27,2010-03-27,2011-05-04 15:42:07+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,193082000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2010.0,Q1,2009-12-27,2010-03-27,2011-05-04 15:42:07+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,193082000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2010.0,Q1,2009-12-27,2010-03-27,2011-05-04 15:42:07+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,99205000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2010.0,Q1,2009-12-27,2010-03-27,2011-05-04 15:42:07+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,62331000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2010.0,Q1,2009-12-27,2010-03-27,2011-05-04 15:42:07+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,6680000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2010.0,Q1,2009-12-27,2010-03-27,2011-05-04 15:42:07+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,69011000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2010.0,Q1,2009-12-27,2010-03-27,2011-05-04 15:42:07+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,30194000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2010.0,Q1,2009-12-27,2010-03-27,2011-05-04 15:42:07+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,6008000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2010.0,Q1,2009-12-27,2010-03-27,2011-05-04 15:42:07+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,357000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2010.0,Q1,2009-12-27,2010-03-27,2011-05-04 15:42:07+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-468000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2010.0,Q1,2009-12-27,2010-03-27,2011-05-04 15:42:07+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-6119000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2010.0,Q1,2009-12-27,2010-03-27,2011-05-04 15:42:07+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,24075000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2010.0,Q1,2009-12-27,2010-03-27,2011-05-04 15:42:07+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,6737000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2010.0,Q1,2009-12-27,2010-03-27,2011-05-04 15:42:07+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,17338000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2010.0,Q1,2009-12-27,2010-03-27,2011-05-04 15:42:07+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-338000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2010.0,Q1,2009-12-27,2010-03-27,2011-05-04 15:42:07+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,17000000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2010.0,Q1,2009-12-27,2010-03-27,2011-05-04 15:42:07+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-382000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2010.0,Q1,2009-12-27,2010-03-27,2011-05-04 15:42:07+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,17382000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2010.0,Q1,2009-12-27,2010-03-27,2011-05-04 15:42:07+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,64400000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2010.0,Q1,2009-12-27,2010-03-27,2011-05-04 15:42:07+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.27
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2010.0,Q1,2009-12-27,2010-03-27,2011-05-04 15:42:07+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,66900000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2010.0,Q1,2009-12-27,2010-03-27,2011-05-04 15:42:07+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.26
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2010.0,Q1,2009-12-27,2010-03-27,2011-05-04 15:42:07+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,64400000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2010.0,Q1,2009-12-27,2010-03-27,2011-05-04 15:42:07+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.27
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2010.0,Q2,2010-03-28,2010-06-26,2011-08-03 14:34:28+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,288592000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2010.0,Q2,2010-03-28,2010-06-26,2011-08-03 14:34:28+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,288592000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2010.0,Q2,2010-03-28,2010-06-26,2011-08-03 14:34:28+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,187828000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2010.0,Q2,2010-03-28,2010-06-26,2011-08-03 14:34:28+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,187828000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2010.0,Q2,2010-03-28,2010-06-26,2011-08-03 14:34:28+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,100764000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2010.0,Q2,2010-03-28,2010-06-26,2011-08-03 14:34:28+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,65240000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2010.0,Q2,2010-03-28,2010-06-26,2011-08-03 14:34:28+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,5539000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2010.0,Q2,2010-03-28,2010-06-26,2011-08-03 14:34:28+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,70779000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2010.0,Q2,2010-03-28,2010-06-26,2011-08-03 14:34:28+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,29985000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2010.0,Q2,2010-03-28,2010-06-26,2011-08-03 14:34:28+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,7104000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2010.0,Q2,2010-03-28,2010-06-26,2011-08-03 14:34:28+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,257000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2010.0,Q2,2010-03-28,2010-06-26,2011-08-03 14:34:28+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-734000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2010.0,Q2,2010-03-28,2010-06-26,2011-08-03 14:34:28+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-7581000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2010.0,Q2,2010-03-28,2010-06-26,2011-08-03 14:34:28+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,22404000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2010.0,Q2,2010-03-28,2010-06-26,2011-08-03 14:34:28+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,7170000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2010.0,Q2,2010-03-28,2010-06-26,2011-08-03 14:34:28+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,15234000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2010.0,Q2,2010-03-28,2010-06-26,2011-08-03 14:34:28+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-1139000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2010.0,Q2,2010-03-28,2010-06-26,2011-08-03 14:34:28+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,14095000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2010.0,Q2,2010-03-28,2010-06-26,2011-08-03 14:34:28+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-359000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2010.0,Q2,2010-03-28,2010-06-26,2011-08-03 14:34:28+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,14454000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2010.0,Q2,2010-03-28,2010-06-26,2011-08-03 14:34:28+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,65700000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2010.0,Q2,2010-03-28,2010-06-26,2011-08-03 14:34:28+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.22
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2010.0,Q2,2010-03-28,2010-06-26,2011-08-03 14:34:28+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,65700000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2010.0,Q2,2010-03-28,2010-06-26,2011-08-03 14:34:28+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.22
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2010.0,Q2,2010-03-28,2010-06-26,2011-08-03 14:34:28+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,65700000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2010.0,Q2,2010-03-28,2010-06-26,2011-08-03 14:34:28+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.22
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2010.0,Q3,2010-06-27,2010-09-25,2011-11-02 16:41:16+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,270885000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2010.0,Q3,2010-06-27,2010-09-25,2011-11-02 16:41:16+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,270885000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2010.0,Q3,2010-06-27,2010-09-25,2011-11-02 16:41:16+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,180385000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2010.0,Q3,2010-06-27,2010-09-25,2011-11-02 16:41:16+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,180385000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2010.0,Q3,2010-06-27,2010-09-25,2011-11-02 16:41:16+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,90500000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2010.0,Q3,2010-06-27,2010-09-25,2011-11-02 16:41:16+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,48005000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2010.0,Q3,2010-06-27,2010-09-25,2011-11-02 16:41:16+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,6027000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2010.0,Q3,2010-06-27,2010-09-25,2011-11-02 16:41:16+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,30000000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2010.0,Q3,2010-06-27,2010-09-25,2011-11-02 16:41:16+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,84032000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2010.0,Q3,2010-06-27,2010-09-25,2011-11-02 16:41:16+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,6468000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2010.0,Q3,2010-06-27,2010-09-25,2011-11-02 16:41:16+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,12641000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2010.0,Q3,2010-06-27,2010-09-25,2011-11-02 16:41:16+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,243000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2010.0,Q3,2010-06-27,2010-09-25,2011-11-02 16:41:16+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1648000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2010.0,Q3,2010-06-27,2010-09-25,2011-11-02 16:41:16+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-14046000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2010.0,Q3,2010-06-27,2010-09-25,2011-11-02 16:41:16+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-7578000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2010.0,Q3,2010-06-27,2010-09-25,2011-11-02 16:41:16+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,16670000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2010.0,Q3,2010-06-27,2010-09-25,2011-11-02 16:41:16+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-24248000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2010.0,Q3,2010-06-27,2010-09-25,2011-11-02 16:41:16+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-986000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2010.0,Q3,2010-06-27,2010-09-25,2011-11-02 16:41:16+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-25234000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2010.0,Q3,2010-06-27,2010-09-25,2011-11-02 16:41:16+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-293000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2010.0,Q3,2010-06-27,2010-09-25,2011-11-02 16:41:16+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-24941000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2010.0,Q3,2010-06-27,2010-09-25,2011-11-02 16:41:16+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,62400000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2010.0,Q3,2010-06-27,2010-09-25,2011-11-02 16:41:16+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.4
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2010.0,Q3,2010-06-27,2010-09-25,2011-11-02 16:41:16+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,62400000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2010.0,Q3,2010-06-27,2010-09-25,2011-11-02 16:41:16+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.4
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2010.0,Q3,2010-06-27,2010-09-25,2011-11-02 16:41:16+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,62400000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2010.0,Q3,2010-06-27,2010-09-25,2011-11-02 16:41:16+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.4
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2010.0,Q4,2010-09-26,2010-12-25,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,281652000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2010.0,Q4,2010-09-26,2010-12-25,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,281652000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2010.0,Q4,2010-09-26,2010-12-25,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,187361000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2010.0,Q4,2010-09-26,2010-12-25,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,187361000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2010.0,Q4,2010-09-26,2010-12-25,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,94291000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2010.0,Q4,2010-09-26,2010-12-25,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,56913000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2010.0,Q4,2010-09-26,2010-12-25,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,6159000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2010.0,Q4,2010-09-26,2010-12-25,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,396378000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2010.0,Q4,2010-09-26,2010-12-25,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,459450000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2010.0,Q4,2010-09-26,2010-12-25,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-365159000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2010.0,Q4,2010-09-26,2010-12-25,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,9526000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2010.0,Q4,2010-09-26,2010-12-25,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,329000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2010.0,Q4,2010-09-26,2010-12-25,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1373000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2010.0,Q4,2010-09-26,2010-12-25,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-7824000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2010.0,Q4,2010-09-26,2010-12-25,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-372983000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2010.0,Q4,2010-09-26,2010-12-25,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-30554000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2010.0,Q4,2010-09-26,2010-12-25,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-342429000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2010.0,Q4,2010-09-26,2010-12-25,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-5549000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2010.0,Q4,2010-09-26,2010-12-25,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-347978000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2010.0,Q4,2010-09-26,2010-12-25,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-4414000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2010.0,Q4,2010-09-26,2010-12-25,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-343564000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2010.0,Q4,2010-09-26,2010-12-25,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,62600000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2010.0,Q4,2010-09-26,2010-12-25,,,basiceps,Basic Earnings per Share,=,,usdpershare,-5.47
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2010.0,Q4,2010-09-26,2010-12-25,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,62600000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2010.0,Q4,2010-09-26,2010-12-25,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-5.46
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2010.0,Q4,2010-09-26,2010-12-25,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,62600000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2010.0,Q4,2010-09-26,2010-12-25,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-5.47
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2011.0,Q1,2010-12-26,2011-03-26,2012-05-04 10:16:31+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,285843000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2011.0,Q1,2010-12-26,2011-03-26,2012-05-04 10:16:31+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,285843000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2011.0,Q1,2010-12-26,2011-03-26,2012-05-04 10:16:31+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,183205000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2011.0,Q1,2010-12-26,2011-03-26,2012-05-04 10:16:31+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,183205000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2011.0,Q1,2010-12-26,2011-03-26,2012-05-04 10:16:31+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,102638000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2011.0,Q1,2010-12-26,2011-03-26,2012-05-04 10:16:31+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,55007000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2011.0,Q1,2010-12-26,2011-03-26,2012-05-04 10:16:31+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,5380000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2011.0,Q1,2010-12-26,2011-03-26,2012-05-04 10:16:31+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,60387000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2011.0,Q1,2010-12-26,2011-03-26,2012-05-04 10:16:31+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,42251000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2011.0,Q1,2010-12-26,2011-03-26,2012-05-04 10:16:31+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,10016000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2011.0,Q1,2010-12-26,2011-03-26,2012-05-04 10:16:31+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,364000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2011.0,Q1,2010-12-26,2011-03-26,2012-05-04 10:16:31+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,63000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2011.0,Q1,2010-12-26,2011-03-26,2012-05-04 10:16:31+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-9589000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2011.0,Q1,2010-12-26,2011-03-26,2012-05-04 10:16:31+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,32662000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2011.0,Q1,2010-12-26,2011-03-26,2012-05-04 10:16:31+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-2715000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2011.0,Q1,2010-12-26,2011-03-26,2012-05-04 10:16:31+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,35377000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2011.0,Q1,2010-12-26,2011-03-26,2012-05-04 10:16:31+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-3945000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2011.0,Q1,2010-12-26,2011-03-26,2012-05-04 10:16:31+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,31432000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2011.0,Q1,2010-12-26,2011-03-26,2012-05-04 10:16:31+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,97000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2011.0,Q1,2010-12-26,2011-03-26,2012-05-04 10:16:31+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,31335000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2011.0,Q1,2010-12-26,2011-03-26,2012-05-04 10:16:31+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,54000000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2011.0,Q1,2010-12-26,2011-03-26,2012-05-04 10:16:31+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.58
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2011.0,Q1,2010-12-26,2011-03-26,2012-05-04 10:16:31+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,55000000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2011.0,Q1,2010-12-26,2011-03-26,2012-05-04 10:16:31+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.57
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2011.0,Q1,2010-12-26,2011-03-26,2012-05-04 10:16:31+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,54000000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2011.0,Q1,2010-12-26,2011-03-26,2012-05-04 10:16:31+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.58
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2011.0,Q2,2011-03-27,2011-06-25,2012-08-07 16:58:28+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,288263000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2011.0,Q2,2011-03-27,2011-06-25,2012-08-07 16:58:28+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,288263000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2011.0,Q2,2011-03-27,2011-06-25,2012-08-07 16:58:28+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,181943000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2011.0,Q2,2011-03-27,2011-06-25,2012-08-07 16:58:28+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,181943000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2011.0,Q2,2011-03-27,2011-06-25,2012-08-07 16:58:28+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,106320000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2011.0,Q2,2011-03-27,2011-06-25,2012-08-07 16:58:28+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,47209000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2011.0,Q2,2011-03-27,2011-06-25,2012-08-07 16:58:28+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,5797000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2011.0,Q2,2011-03-27,2011-06-25,2012-08-07 16:58:28+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,53006000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2011.0,Q2,2011-03-27,2011-06-25,2012-08-07 16:58:28+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,53314000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2011.0,Q2,2011-03-27,2011-06-25,2012-08-07 16:58:28+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,10659000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2011.0,Q2,2011-03-27,2011-06-25,2012-08-07 16:58:28+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,558000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2011.0,Q2,2011-03-27,2011-06-25,2012-08-07 16:58:28+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-408000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2011.0,Q2,2011-03-27,2011-06-25,2012-08-07 16:58:28+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-10509000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2011.0,Q2,2011-03-27,2011-06-25,2012-08-07 16:58:28+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,42805000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2011.0,Q2,2011-03-27,2011-06-25,2012-08-07 16:58:28+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,8649000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2011.0,Q2,2011-03-27,2011-06-25,2012-08-07 16:58:28+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,34156000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2011.0,Q2,2011-03-27,2011-06-25,2012-08-07 16:58:28+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-1732000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2011.0,Q2,2011-03-27,2011-06-25,2012-08-07 16:58:28+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,32424000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2011.0,Q2,2011-03-27,2011-06-25,2012-08-07 16:58:28+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,106000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2011.0,Q2,2011-03-27,2011-06-25,2012-08-07 16:58:28+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,32318000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2011.0,Q2,2011-03-27,2011-06-25,2012-08-07 16:58:28+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,51300000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2011.0,Q2,2011-03-27,2011-06-25,2012-08-07 16:58:28+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.63
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2011.0,Q2,2011-03-27,2011-06-25,2012-08-07 16:58:28+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,51300000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2011.0,Q2,2011-03-27,2011-06-25,2012-08-07 16:58:28+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.63
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2011.0,Q2,2011-03-27,2011-06-25,2012-08-07 16:58:28+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,51300000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2011.0,Q2,2011-03-27,2011-06-25,2012-08-07 16:58:28+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.63
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2011.0,Q3,2011-06-26,2011-09-24,2012-11-01 09:54:30+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,277579000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2011.0,Q3,2011-06-26,2011-09-24,2012-11-01 09:54:30+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,277579000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2011.0,Q3,2011-06-26,2011-09-24,2012-11-01 09:54:30+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,184863000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2011.0,Q3,2011-06-26,2011-09-24,2012-11-01 09:54:30+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,184863000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2011.0,Q3,2011-06-26,2011-09-24,2012-11-01 09:54:30+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,92716000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2011.0,Q3,2011-06-26,2011-09-24,2012-11-01 09:54:30+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,50345000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2011.0,Q3,2011-06-26,2011-09-24,2012-11-01 09:54:30+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,5277000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2011.0,Q3,2011-06-26,2011-09-24,2012-11-01 09:54:30+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,55622000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2011.0,Q3,2011-06-26,2011-09-24,2012-11-01 09:54:30+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,37094000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2011.0,Q3,2011-06-26,2011-09-24,2012-11-01 09:54:30+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,11944000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2011.0,Q3,2011-06-26,2011-09-24,2012-11-01 09:54:30+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,138000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2011.0,Q3,2011-06-26,2011-09-24,2012-11-01 09:54:30+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-747000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2011.0,Q3,2011-06-26,2011-09-24,2012-11-01 09:54:30+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-12553000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2011.0,Q3,2011-06-26,2011-09-24,2012-11-01 09:54:30+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,24541000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2011.0,Q3,2011-06-26,2011-09-24,2012-11-01 09:54:30+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,5630000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2011.0,Q3,2011-06-26,2011-09-24,2012-11-01 09:54:30+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,18911000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2011.0,Q3,2011-06-26,2011-09-24,2012-11-01 09:54:30+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-18000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2011.0,Q3,2011-06-26,2011-09-24,2012-11-01 09:54:30+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,18893000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2011.0,Q3,2011-06-26,2011-09-24,2012-11-01 09:54:30+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,95000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2011.0,Q3,2011-06-26,2011-09-24,2012-11-01 09:54:30+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,18798000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2011.0,Q3,2011-06-26,2011-09-24,2012-11-01 09:54:30+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,49500000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2011.0,Q3,2011-06-26,2011-09-24,2012-11-01 09:54:30+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.38
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2011.0,Q3,2011-06-26,2011-09-24,2012-11-01 09:54:30+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,50800000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2011.0,Q3,2011-06-26,2011-09-24,2012-11-01 09:54:30+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.37
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2011.0,Q3,2011-06-26,2011-09-24,2012-11-01 09:54:30+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,49500000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2011.0,Q3,2011-06-26,2011-09-24,2012-11-01 09:54:30+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.38
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2011.0,Q4,2011-09-25,2011-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,290962000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2011.0,Q4,2011-09-25,2011-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,290962000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2011.0,Q4,2011-09-25,2011-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,190394000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2011.0,Q4,2011-09-25,2011-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,190394000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2011.0,Q4,2011-09-25,2011-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,100568000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2011.0,Q4,2011-09-25,2011-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,46087000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2011.0,Q4,2011-09-25,2011-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,5342000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2011.0,Q4,2011-09-25,2011-12-31,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,7492000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2011.0,Q4,2011-09-25,2011-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,58921000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2011.0,Q4,2011-09-25,2011-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,41647000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2011.0,Q4,2011-09-25,2011-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,9967000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2011.0,Q4,2011-09-25,2011-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,293000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2011.0,Q4,2011-09-25,2011-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,681000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2011.0,Q4,2011-09-25,2011-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-8993000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2011.0,Q4,2011-09-25,2011-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,32654000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2011.0,Q4,2011-09-25,2011-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,5576000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2011.0,Q4,2011-09-25,2011-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,27078000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2011.0,Q4,2011-09-25,2011-12-31,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,150000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2011.0,Q4,2011-09-25,2011-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,27228000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2011.0,Q4,2011-09-25,2011-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,113000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2011.0,Q4,2011-09-25,2011-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,27115000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2011.0,Q4,2011-09-25,2011-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,50700000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2011.0,Q4,2011-09-25,2011-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.57
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2011.0,Q4,2011-09-25,2011-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,51200000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2011.0,Q4,2011-09-25,2011-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.57
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2011.0,Q4,2011-09-25,2011-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,50700000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2011.0,Q4,2011-09-25,2011-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.57
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 13:44:06+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,285981000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 13:44:06+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,285981000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 13:44:06+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,181769000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 13:44:06+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,181769000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 13:44:06+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,104212000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 13:44:06+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,55977000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 13:44:06+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,4495000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 13:44:06+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,60472000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 13:44:06+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,43740000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 13:44:06+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,8435000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 13:44:06+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,185000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 13:44:06+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-344000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 13:44:06+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-8594000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 13:44:06+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,35146000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 13:44:06+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,8676000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 13:44:06+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,26470000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 13:44:06+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,77000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 13:44:06+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,26547000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 13:44:06+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,108000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 13:44:06+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,26439000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 13:44:06+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,48100000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 13:44:06+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.55
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 13:44:06+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,49000000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 13:44:06+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.54
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 13:44:06+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,48100000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2012.0,Q1,2012-01-01,2012-03-31,2013-05-08 13:44:06+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.55
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2012.0,Q2,2012-04-01,2012-06-30,2013-07-31 16:32:47+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,284723000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2012.0,Q2,2012-04-01,2012-06-30,2013-07-31 16:32:47+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,284723000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2012.0,Q2,2012-04-01,2012-06-30,2013-07-31 16:32:47+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,181138000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2012.0,Q2,2012-04-01,2012-06-30,2013-07-31 16:32:47+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,181138000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2012.0,Q2,2012-04-01,2012-06-30,2013-07-31 16:32:47+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,103585000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2012.0,Q2,2012-04-01,2012-06-30,2013-07-31 16:32:47+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,49900000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2012.0,Q2,2012-04-01,2012-06-30,2013-07-31 16:32:47+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,4411000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2012.0,Q2,2012-04-01,2012-06-30,2013-07-31 16:32:47+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,54311000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2012.0,Q2,2012-04-01,2012-06-30,2013-07-31 16:32:47+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,49274000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2012.0,Q2,2012-04-01,2012-06-30,2013-07-31 16:32:47+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,8079000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2012.0,Q2,2012-04-01,2012-06-30,2013-07-31 16:32:47+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,151000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2012.0,Q2,2012-04-01,2012-06-30,2013-07-31 16:32:47+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1346000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2012.0,Q2,2012-04-01,2012-06-30,2013-07-31 16:32:47+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-9274000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2012.0,Q2,2012-04-01,2012-06-30,2013-07-31 16:32:47+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,40000000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2012.0,Q2,2012-04-01,2012-06-30,2013-07-31 16:32:47+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,9453000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2012.0,Q2,2012-04-01,2012-06-30,2013-07-31 16:32:47+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,30547000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2012.0,Q2,2012-04-01,2012-06-30,2013-07-31 16:32:47+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,42000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2012.0,Q2,2012-04-01,2012-06-30,2013-07-31 16:32:47+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,30589000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2012.0,Q2,2012-04-01,2012-06-30,2013-07-31 16:32:47+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,121000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2012.0,Q2,2012-04-01,2012-06-30,2013-07-31 16:32:47+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,30468000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2012.0,Q2,2012-04-01,2012-06-30,2013-07-31 16:32:47+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,48400000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2012.0,Q2,2012-04-01,2012-06-30,2013-07-31 16:32:47+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.63
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2012.0,Q2,2012-04-01,2012-06-30,2013-07-31 16:32:47+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,48400000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2012.0,Q2,2012-04-01,2012-06-30,2013-07-31 16:32:47+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.63
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2012.0,Q2,2012-04-01,2012-06-30,2013-07-31 16:32:47+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,48400000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2012.0,Q2,2012-04-01,2012-06-30,2013-07-31 16:32:47+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.63
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2012.0,Q3,2012-07-01,2012-09-29,2013-10-30 15:05:26+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,278686000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2012.0,Q3,2012-07-01,2012-09-29,2013-10-30 15:05:26+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,278686000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2012.0,Q3,2012-07-01,2012-09-29,2013-10-30 15:05:26+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,185427000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2012.0,Q3,2012-07-01,2012-09-29,2013-10-30 15:05:26+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,185427000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2012.0,Q3,2012-07-01,2012-09-29,2013-10-30 15:05:26+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,93259000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2012.0,Q3,2012-07-01,2012-09-29,2013-10-30 15:05:26+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,51047000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2012.0,Q3,2012-07-01,2012-09-29,2013-10-30 15:05:26+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,4530000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2012.0,Q3,2012-07-01,2012-09-29,2013-10-30 15:05:26+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,55577000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2012.0,Q3,2012-07-01,2012-09-29,2013-10-30 15:05:26+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,37682000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2012.0,Q3,2012-07-01,2012-09-29,2013-10-30 15:05:26+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,8519000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2012.0,Q3,2012-07-01,2012-09-29,2013-10-30 15:05:26+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,124000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2012.0,Q3,2012-07-01,2012-09-29,2013-10-30 15:05:26+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-892000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2012.0,Q3,2012-07-01,2012-09-29,2013-10-30 15:05:26+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-9287000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2012.0,Q3,2012-07-01,2012-09-29,2013-10-30 15:05:26+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,28395000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2012.0,Q3,2012-07-01,2012-09-29,2013-10-30 15:05:26+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,6011000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2012.0,Q3,2012-07-01,2012-09-29,2013-10-30 15:05:26+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,22384000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2012.0,Q3,2012-07-01,2012-09-29,2013-10-30 15:05:26+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-182000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2012.0,Q3,2012-07-01,2012-09-29,2013-10-30 15:05:26+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,22202000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2012.0,Q3,2012-07-01,2012-09-29,2013-10-30 15:05:26+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,230000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2012.0,Q3,2012-07-01,2012-09-29,2013-10-30 15:05:26+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,21972000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2012.0,Q3,2012-07-01,2012-09-29,2013-10-30 15:05:26+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,47800000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2012.0,Q3,2012-07-01,2012-09-29,2013-10-30 15:05:26+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.46
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2012.0,Q3,2012-07-01,2012-09-29,2013-10-30 15:05:26+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,47800000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2012.0,Q3,2012-07-01,2012-09-29,2013-10-30 15:05:26+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.46
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2012.0,Q3,2012-07-01,2012-09-29,2013-10-30 15:05:26+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,47800000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2012.0,Q3,2012-07-01,2012-09-29,2013-10-30 15:05:26+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.46
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2012.0,Q4,2012-09-30,2012-12-29,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,280140000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2012.0,Q4,2012-09-30,2012-12-29,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,280140000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2012.0,Q4,2012-09-30,2012-12-29,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,185567000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2012.0,Q4,2012-09-30,2012-12-29,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,185567000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2012.0,Q4,2012-09-30,2012-12-29,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,94573000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2012.0,Q4,2012-09-30,2012-12-29,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,51324000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2012.0,Q4,2012-09-30,2012-12-29,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,4632000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2012.0,Q4,2012-09-30,2012-12-29,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,3548000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2012.0,Q4,2012-09-30,2012-12-29,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,59504000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2012.0,Q4,2012-09-30,2012-12-29,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,35069000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2012.0,Q4,2012-09-30,2012-12-29,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,8309000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2012.0,Q4,2012-09-30,2012-12-29,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,129000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2012.0,Q4,2012-09-30,2012-12-29,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-684000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2012.0,Q4,2012-09-30,2012-12-29,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-8864000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2012.0,Q4,2012-09-30,2012-12-29,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,26205000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2012.0,Q4,2012-09-30,2012-12-29,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,3488000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2012.0,Q4,2012-09-30,2012-12-29,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,22717000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2012.0,Q4,2012-09-30,2012-12-29,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-4189000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2012.0,Q4,2012-09-30,2012-12-29,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,18528000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2012.0,Q4,2012-09-30,2012-12-29,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,112000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2012.0,Q4,2012-09-30,2012-12-29,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,18416000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2012.0,Q4,2012-09-30,2012-12-29,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,47900000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2012.0,Q4,2012-09-30,2012-12-29,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.39
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2012.0,Q4,2012-09-30,2012-12-29,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,48400000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2012.0,Q4,2012-09-30,2012-12-29,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.38
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2012.0,Q4,2012-09-30,2012-12-29,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,47900000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2012.0,Q4,2012-09-30,2012-12-29,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.39
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2013.0,Q1,2012-12-30,2013-03-30,2014-04-30 16:43:41+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,291238000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2013.0,Q1,2012-12-30,2013-03-30,2014-04-30 16:43:41+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,291238000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2013.0,Q1,2012-12-30,2013-03-30,2014-04-30 16:43:41+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,187027000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2013.0,Q1,2012-12-30,2013-03-30,2014-04-30 16:43:41+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,187027000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2013.0,Q1,2012-12-30,2013-03-30,2014-04-30 16:43:41+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,104211000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2013.0,Q1,2012-12-30,2013-03-30,2014-04-30 16:43:41+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,57199000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2013.0,Q1,2012-12-30,2013-03-30,2014-04-30 16:43:41+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,4249000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2013.0,Q1,2012-12-30,2013-03-30,2014-04-30 16:43:41+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,61448000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2013.0,Q1,2012-12-30,2013-03-30,2014-04-30 16:43:41+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,42763000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2013.0,Q1,2012-12-30,2013-03-30,2014-04-30 16:43:41+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,8280000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2013.0,Q1,2012-12-30,2013-03-30,2014-04-30 16:43:41+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,97000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2013.0,Q1,2012-12-30,2013-03-30,2014-04-30 16:43:41+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1068000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2013.0,Q1,2012-12-30,2013-03-30,2014-04-30 16:43:41+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-7115000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2013.0,Q1,2012-12-30,2013-03-30,2014-04-30 16:43:41+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,35648000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2013.0,Q1,2012-12-30,2013-03-30,2014-04-30 16:43:41+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,9722000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2013.0,Q1,2012-12-30,2013-03-30,2014-04-30 16:43:41+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,25926000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2013.0,Q1,2012-12-30,2013-03-30,2014-04-30 16:43:41+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-155000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2013.0,Q1,2012-12-30,2013-03-30,2014-04-30 16:43:41+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,25771000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2013.0,Q1,2012-12-30,2013-03-30,2014-04-30 16:43:41+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,193000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2013.0,Q1,2012-12-30,2013-03-30,2014-04-30 16:43:41+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,25578000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2013.0,Q1,2012-12-30,2013-03-30,2014-04-30 16:43:41+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,47400000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2013.0,Q1,2012-12-30,2013-03-30,2014-04-30 16:43:41+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.54
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2013.0,Q1,2012-12-30,2013-03-30,2014-04-30 16:43:41+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,48300000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2013.0,Q1,2012-12-30,2013-03-30,2014-04-30 16:43:41+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.53
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2013.0,Q1,2012-12-30,2013-03-30,2014-04-30 16:43:41+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,47400000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2013.0,Q1,2012-12-30,2013-03-30,2014-04-30 16:43:41+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.54
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2013.0,Q2,2013-03-31,2013-06-29,2014-08-07 15:08:51+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,292933000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2013.0,Q2,2013-03-31,2013-06-29,2014-08-07 15:08:51+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,292933000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2013.0,Q2,2013-03-31,2013-06-29,2014-08-07 15:08:51+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,190363000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2013.0,Q2,2013-03-31,2013-06-29,2014-08-07 15:08:51+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,190363000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2013.0,Q2,2013-03-31,2013-06-29,2014-08-07 15:08:51+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,102570000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2013.0,Q2,2013-03-31,2013-06-29,2014-08-07 15:08:51+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,54919000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2013.0,Q2,2013-03-31,2013-06-29,2014-08-07 15:08:51+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,4463000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2013.0,Q2,2013-03-31,2013-06-29,2014-08-07 15:08:51+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,59382000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2013.0,Q2,2013-03-31,2013-06-29,2014-08-07 15:08:51+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,43188000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2013.0,Q2,2013-03-31,2013-06-29,2014-08-07 15:08:51+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,7544000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2013.0,Q2,2013-03-31,2013-06-29,2014-08-07 15:08:51+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,236000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2013.0,Q2,2013-03-31,2013-06-29,2014-08-07 15:08:51+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,967000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2013.0,Q2,2013-03-31,2013-06-29,2014-08-07 15:08:51+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-6341000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2013.0,Q2,2013-03-31,2013-06-29,2014-08-07 15:08:51+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,36847000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2013.0,Q2,2013-03-31,2013-06-29,2014-08-07 15:08:51+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,8219000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2013.0,Q2,2013-03-31,2013-06-29,2014-08-07 15:08:51+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,28628000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2013.0,Q2,2013-03-31,2013-06-29,2014-08-07 15:08:51+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-915000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2013.0,Q2,2013-03-31,2013-06-29,2014-08-07 15:08:51+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,27713000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2013.0,Q2,2013-03-31,2013-06-29,2014-08-07 15:08:51+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,429000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2013.0,Q2,2013-03-31,2013-06-29,2014-08-07 15:08:51+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,27284000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2013.0,Q2,2013-03-31,2013-06-29,2014-08-07 15:08:51+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,47900000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2013.0,Q2,2013-03-31,2013-06-29,2014-08-07 15:08:51+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.57
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2013.0,Q2,2013-03-31,2013-06-29,2014-08-07 15:08:51+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,48700000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2013.0,Q2,2013-03-31,2013-06-29,2014-08-07 15:08:51+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.56
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2013.0,Q2,2013-03-31,2013-06-29,2014-08-07 15:08:51+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,47900000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2013.0,Q2,2013-03-31,2013-06-29,2014-08-07 15:08:51+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.57
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2013.0,Q3,2013-06-30,2013-09-28,2014-10-30 14:51:12+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,292129000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2013.0,Q3,2013-06-30,2013-09-28,2014-10-30 14:51:12+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,292129000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2013.0,Q3,2013-06-30,2013-09-28,2014-10-30 14:51:12+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,192203000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2013.0,Q3,2013-06-30,2013-09-28,2014-10-30 14:51:12+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,192203000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2013.0,Q3,2013-06-30,2013-09-28,2014-10-30 14:51:12+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,99926000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2013.0,Q3,2013-06-30,2013-09-28,2014-10-30 14:51:12+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,54903000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2013.0,Q3,2013-06-30,2013-09-28,2014-10-30 14:51:12+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,4180000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2013.0,Q3,2013-06-30,2013-09-28,2014-10-30 14:51:12+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,59083000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2013.0,Q3,2013-06-30,2013-09-28,2014-10-30 14:51:12+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,40843000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2013.0,Q3,2013-06-30,2013-09-28,2014-10-30 14:51:12+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2319000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2013.0,Q3,2013-06-30,2013-09-28,2014-10-30 14:51:12+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,143000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2013.0,Q3,2013-06-30,2013-09-28,2014-10-30 14:51:12+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,4059000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2013.0,Q3,2013-06-30,2013-09-28,2014-10-30 14:51:12+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1883000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2013.0,Q3,2013-06-30,2013-09-28,2014-10-30 14:51:12+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,42726000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2013.0,Q3,2013-06-30,2013-09-28,2014-10-30 14:51:12+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,11390000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2013.0,Q3,2013-06-30,2013-09-28,2014-10-30 14:51:12+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,31336000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2013.0,Q3,2013-06-30,2013-09-28,2014-10-30 14:51:12+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-113000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2013.0,Q3,2013-06-30,2013-09-28,2014-10-30 14:51:12+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,31223000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2013.0,Q3,2013-06-30,2013-09-28,2014-10-30 14:51:12+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,356000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2013.0,Q3,2013-06-30,2013-09-28,2014-10-30 14:51:12+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,30867000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2013.0,Q3,2013-06-30,2013-09-28,2014-10-30 14:51:12+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,48200000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2013.0,Q3,2013-06-30,2013-09-28,2014-10-30 14:51:12+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.64
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2013.0,Q3,2013-06-30,2013-09-28,2014-10-30 14:51:12+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,48200000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2013.0,Q3,2013-06-30,2013-09-28,2014-10-30 14:51:12+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.64
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2013.0,Q3,2013-06-30,2013-09-28,2014-10-30 14:51:12+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,48200000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2013.0,Q3,2013-06-30,2013-09-28,2014-10-30 14:51:12+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.64
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2013.0,Q4,2013-09-29,2013-12-28,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,289228000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2013.0,Q4,2013-09-29,2013-12-28,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,289228000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2013.0,Q4,2013-09-29,2013-12-28,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,201033000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2013.0,Q4,2013-09-29,2013-12-28,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,201033000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2013.0,Q4,2013-09-29,2013-12-28,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,88195000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2013.0,Q4,2013-09-29,2013-12-28,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,58674000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2013.0,Q4,2013-09-29,2013-12-28,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,4914000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2013.0,Q4,2013-09-29,2013-12-28,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,63588000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2013.0,Q4,2013-09-29,2013-12-28,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,24607000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2013.0,Q4,2013-09-29,2013-12-28,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2826000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2013.0,Q4,2013-09-29,2013-12-28,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,254000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2013.0,Q4,2013-09-29,2013-12-28,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1071000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2013.0,Q4,2013-09-29,2013-12-28,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1501000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2013.0,Q4,2013-09-29,2013-12-28,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,23106000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2013.0,Q4,2013-09-29,2013-12-28,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,3580000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2013.0,Q4,2013-09-29,2013-12-28,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,19526000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2013.0,Q4,2013-09-29,2013-12-28,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-82000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2013.0,Q4,2013-09-29,2013-12-28,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,19444000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2013.0,Q4,2013-09-29,2013-12-28,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,345000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2013.0,Q4,2013-09-29,2013-12-28,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,19099000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2013.0,Q4,2013-09-29,2013-12-28,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,47800000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2013.0,Q4,2013-09-29,2013-12-28,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.4
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2013.0,Q4,2013-09-29,2013-12-28,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,48500000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2013.0,Q4,2013-09-29,2013-12-28,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.39
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2013.0,Q4,2013-09-29,2013-12-28,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,47800000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2013.0,Q4,2013-09-29,2013-12-28,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.4
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2014.0,Q1,2013-12-29,2014-03-29,2015-04-30 14:22:13+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,299368000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2014.0,Q1,2013-12-29,2014-03-29,2015-04-30 14:22:13+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,299368000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2014.0,Q1,2013-12-29,2014-03-29,2015-04-30 14:22:13+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,190555000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2014.0,Q1,2013-12-29,2014-03-29,2015-04-30 14:22:13+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,190555000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2014.0,Q1,2013-12-29,2014-03-29,2015-04-30 14:22:13+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,108813000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2014.0,Q1,2013-12-29,2014-03-29,2015-04-30 14:22:13+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,64767000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2014.0,Q1,2013-12-29,2014-03-29,2015-04-30 14:22:13+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,4340000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2014.0,Q1,2013-12-29,2014-03-29,2015-04-30 14:22:13+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,69107000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2014.0,Q1,2013-12-29,2014-03-29,2015-04-30 14:22:13+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,39706000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2014.0,Q1,2013-12-29,2014-03-29,2015-04-30 14:22:13+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2801000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2014.0,Q1,2013-12-29,2014-03-29,2015-04-30 14:22:13+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,205000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2014.0,Q1,2013-12-29,2014-03-29,2015-04-30 14:22:13+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,5876000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2014.0,Q1,2013-12-29,2014-03-29,2015-04-30 14:22:13+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,3280000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2014.0,Q1,2013-12-29,2014-03-29,2015-04-30 14:22:13+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,42986000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2014.0,Q1,2013-12-29,2014-03-29,2015-04-30 14:22:13+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,10358000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2014.0,Q1,2013-12-29,2014-03-29,2015-04-30 14:22:13+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,32628000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2014.0,Q1,2013-12-29,2014-03-29,2015-04-30 14:22:13+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-270000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2014.0,Q1,2013-12-29,2014-03-29,2015-04-30 14:22:13+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,32358000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2014.0,Q1,2013-12-29,2014-03-29,2015-04-30 14:22:13+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,126000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2014.0,Q1,2013-12-29,2014-03-29,2015-04-30 14:22:13+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,32232000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2014.0,Q1,2013-12-29,2014-03-29,2015-04-30 14:22:13+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,47400000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2014.0,Q1,2013-12-29,2014-03-29,2015-04-30 14:22:13+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.68
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2014.0,Q1,2013-12-29,2014-03-29,2015-04-30 14:22:13+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,48100000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2014.0,Q1,2013-12-29,2014-03-29,2015-04-30 14:22:13+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.67
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2014.0,Q1,2013-12-29,2014-03-29,2015-04-30 14:22:13+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,47400000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2014.0,Q1,2013-12-29,2014-03-29,2015-04-30 14:22:13+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.68
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2014.0,Q2,2014-03-30,2014-06-28,2015-07-30 14:09:02+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,341179000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2014.0,Q2,2014-03-30,2014-06-28,2015-07-30 14:09:02+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,341179000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2014.0,Q2,2014-03-30,2014-06-28,2015-07-30 14:09:02+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,215545000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2014.0,Q2,2014-03-30,2014-06-28,2015-07-30 14:09:02+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,215545000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2014.0,Q2,2014-03-30,2014-06-28,2015-07-30 14:09:02+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,125634000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2014.0,Q2,2014-03-30,2014-06-28,2015-07-30 14:09:02+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,67756000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2014.0,Q2,2014-03-30,2014-06-28,2015-07-30 14:09:02+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,6853000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2014.0,Q2,2014-03-30,2014-06-28,2015-07-30 14:09:02+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,74609000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2014.0,Q2,2014-03-30,2014-06-28,2015-07-30 14:09:02+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,51025000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2014.0,Q2,2014-03-30,2014-06-28,2015-07-30 14:09:02+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3373000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2014.0,Q2,2014-03-30,2014-06-28,2015-07-30 14:09:02+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,222000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2014.0,Q2,2014-03-30,2014-06-28,2015-07-30 14:09:02+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,2667000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2014.0,Q2,2014-03-30,2014-06-28,2015-07-30 14:09:02+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-484000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2014.0,Q2,2014-03-30,2014-06-28,2015-07-30 14:09:02+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,50541000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2014.0,Q2,2014-03-30,2014-06-28,2015-07-30 14:09:02+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,14081000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2014.0,Q2,2014-03-30,2014-06-28,2015-07-30 14:09:02+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,36460000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2014.0,Q2,2014-03-30,2014-06-28,2015-07-30 14:09:02+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-644000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2014.0,Q2,2014-03-30,2014-06-28,2015-07-30 14:09:02+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,35816000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2014.0,Q2,2014-03-30,2014-06-28,2015-07-30 14:09:02+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,552000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2014.0,Q2,2014-03-30,2014-06-28,2015-07-30 14:09:02+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,35264000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2014.0,Q2,2014-03-30,2014-06-28,2015-07-30 14:09:02+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,47000000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2014.0,Q2,2014-03-30,2014-06-28,2015-07-30 14:09:02+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.75
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2014.0,Q2,2014-03-30,2014-06-28,2015-07-30 14:09:02+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,47700000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2014.0,Q2,2014-03-30,2014-06-28,2015-07-30 14:09:02+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.74
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2014.0,Q2,2014-03-30,2014-06-28,2015-07-30 14:09:02+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,47000000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2014.0,Q2,2014-03-30,2014-06-28,2015-07-30 14:09:02+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.75
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2014.0,Q3,2014-06-29,2014-09-27,2015-11-04 11:59:52+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,327567000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2014.0,Q3,2014-06-29,2014-09-27,2015-11-04 11:59:52+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,327567000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2014.0,Q3,2014-06-29,2014-09-27,2015-11-04 11:59:52+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,209299000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2014.0,Q3,2014-06-29,2014-09-27,2015-11-04 11:59:52+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,209299000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2014.0,Q3,2014-06-29,2014-09-27,2015-11-04 11:59:52+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,118268000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2014.0,Q3,2014-06-29,2014-09-27,2015-11-04 11:59:52+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,64476000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2014.0,Q3,2014-06-29,2014-09-27,2015-11-04 11:59:52+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,7620000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2014.0,Q3,2014-06-29,2014-09-27,2015-11-04 11:59:52+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,72096000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2014.0,Q3,2014-06-29,2014-09-27,2015-11-04 11:59:52+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,46172000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2014.0,Q3,2014-06-29,2014-09-27,2015-11-04 11:59:52+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2997000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2014.0,Q3,2014-06-29,2014-09-27,2015-11-04 11:59:52+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,376000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2014.0,Q3,2014-06-29,2014-09-27,2015-11-04 11:59:52+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,331000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2014.0,Q3,2014-06-29,2014-09-27,2015-11-04 11:59:52+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2290000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2014.0,Q3,2014-06-29,2014-09-27,2015-11-04 11:59:52+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,43882000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2014.0,Q3,2014-06-29,2014-09-27,2015-11-04 11:59:52+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,11582000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2014.0,Q3,2014-06-29,2014-09-27,2015-11-04 11:59:52+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,32300000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2014.0,Q3,2014-06-29,2014-09-27,2015-11-04 11:59:52+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,52000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2014.0,Q3,2014-06-29,2014-09-27,2015-11-04 11:59:52+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,32352000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2014.0,Q3,2014-06-29,2014-09-27,2015-11-04 11:59:52+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,316000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2014.0,Q3,2014-06-29,2014-09-27,2015-11-04 11:59:52+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,32036000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2014.0,Q3,2014-06-29,2014-09-27,2015-11-04 11:59:52+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,45800000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2014.0,Q3,2014-06-29,2014-09-27,2015-11-04 11:59:52+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.7
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2014.0,Q3,2014-06-29,2014-09-27,2015-11-04 11:59:52+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,47100000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2014.0,Q3,2014-06-29,2014-09-27,2015-11-04 11:59:52+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.68
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2014.0,Q3,2014-06-29,2014-09-27,2015-11-04 11:59:52+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,45800000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2014.0,Q3,2014-06-29,2014-09-27,2015-11-04 11:59:52+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.7
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2014.0,Q4,2014-09-28,2014-12-27,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,329548000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2014.0,Q4,2014-09-28,2014-12-27,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,329548000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2014.0,Q4,2014-09-28,2014-12-27,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,209603000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2014.0,Q4,2014-09-28,2014-12-27,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,209603000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2014.0,Q4,2014-09-28,2014-12-27,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,119945000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2014.0,Q4,2014-09-28,2014-12-27,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,72034000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2014.0,Q4,2014-09-28,2014-12-27,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,7144000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2014.0,Q4,2014-09-28,2014-12-27,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,79178000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2014.0,Q4,2014-09-28,2014-12-27,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,40767000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2014.0,Q4,2014-09-28,2014-12-27,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2779000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2014.0,Q4,2014-09-28,2014-12-27,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,351000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2014.0,Q4,2014-09-28,2014-12-27,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1847000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2014.0,Q4,2014-09-28,2014-12-27,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-581000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2014.0,Q4,2014-09-28,2014-12-27,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,40186000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2014.0,Q4,2014-09-28,2014-12-27,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,11650000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2014.0,Q4,2014-09-28,2014-12-27,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,28536000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2014.0,Q4,2014-09-28,2014-12-27,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-864000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2014.0,Q4,2014-09-28,2014-12-27,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,27672000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2014.0,Q4,2014-09-28,2014-12-27,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,506000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2014.0,Q4,2014-09-28,2014-12-27,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,27166000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2014.0,Q4,2014-09-28,2014-12-27,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,46600000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2014.0,Q4,2014-09-28,2014-12-27,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.59
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2014.0,Q4,2014-09-28,2014-12-27,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,47600000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2014.0,Q4,2014-09-28,2014-12-27,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.57
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2014.0,Q4,2014-09-28,2014-12-27,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,46600000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2014.0,Q4,2014-09-28,2014-12-27,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.59
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2015.0,Q1,2014-12-28,2015-03-28,2016-05-04 14:45:43+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,320414000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2015.0,Q1,2014-12-28,2015-03-28,2016-05-04 14:45:43+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,320414000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2015.0,Q1,2014-12-28,2015-03-28,2016-05-04 14:45:43+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,200754000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2015.0,Q1,2014-12-28,2015-03-28,2016-05-04 14:45:43+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,200754000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2015.0,Q1,2014-12-28,2015-03-28,2016-05-04 14:45:43+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,119660000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2015.0,Q1,2014-12-28,2015-03-28,2016-05-04 14:45:43+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,71397000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2015.0,Q1,2014-12-28,2015-03-28,2016-05-04 14:45:43+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,5258000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2015.0,Q1,2014-12-28,2015-03-28,2016-05-04 14:45:43+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,76655000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2015.0,Q1,2014-12-28,2015-03-28,2016-05-04 14:45:43+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,43005000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2015.0,Q1,2014-12-28,2015-03-28,2016-05-04 14:45:43+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3024000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2015.0,Q1,2014-12-28,2015-03-28,2016-05-04 14:45:43+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,284000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2015.0,Q1,2014-12-28,2015-03-28,2016-05-04 14:45:43+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-8313000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2015.0,Q1,2014-12-28,2015-03-28,2016-05-04 14:45:43+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-11053000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2015.0,Q1,2014-12-28,2015-03-28,2016-05-04 14:45:43+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,31952000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2015.0,Q1,2014-12-28,2015-03-28,2016-05-04 14:45:43+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,331000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2015.0,Q1,2014-12-28,2015-03-28,2016-05-04 14:45:43+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,31621000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2015.0,Q1,2014-12-28,2015-03-28,2016-05-04 14:45:43+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-7000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2015.0,Q1,2014-12-28,2015-03-28,2016-05-04 14:45:43+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,31614000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2015.0,Q1,2014-12-28,2015-03-28,2016-05-04 14:45:43+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,73000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2015.0,Q1,2014-12-28,2015-03-28,2016-05-04 14:45:43+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,31541000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2015.0,Q1,2014-12-28,2015-03-28,2016-05-04 14:45:43+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,47100000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2015.0,Q1,2014-12-28,2015-03-28,2016-05-04 14:45:43+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.67
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2015.0,Q1,2014-12-28,2015-03-28,2016-05-04 14:45:43+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,47800000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2015.0,Q1,2014-12-28,2015-03-28,2016-05-04 14:45:43+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.66
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2015.0,Q1,2014-12-28,2015-03-28,2016-05-04 14:45:43+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,47100000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2015.0,Q1,2014-12-28,2015-03-28,2016-05-04 14:45:43+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.67
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2015.0,Q2,2015-03-29,2015-06-27,2016-08-03 14:09:58+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,339573000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2015.0,Q2,2015-03-29,2015-06-27,2016-08-03 14:09:58+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,339573000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2015.0,Q2,2015-03-29,2015-06-27,2016-08-03 14:09:58+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,206790000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2015.0,Q2,2015-03-29,2015-06-27,2016-08-03 14:09:58+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,206790000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2015.0,Q2,2015-03-29,2015-06-27,2016-08-03 14:09:58+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,132783000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2015.0,Q2,2015-03-29,2015-06-27,2016-08-03 14:09:58+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,71331000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2015.0,Q2,2015-03-29,2015-06-27,2016-08-03 14:09:58+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,5717000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2015.0,Q2,2015-03-29,2015-06-27,2016-08-03 14:09:58+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,77048000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2015.0,Q2,2015-03-29,2015-06-27,2016-08-03 14:09:58+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,55735000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2015.0,Q2,2015-03-29,2015-06-27,2016-08-03 14:09:58+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4376000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2015.0,Q2,2015-03-29,2015-06-27,2016-08-03 14:09:58+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,297000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2015.0,Q2,2015-03-29,2015-06-27,2016-08-03 14:09:58+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,8672000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2015.0,Q2,2015-03-29,2015-06-27,2016-08-03 14:09:58+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,4593000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2015.0,Q2,2015-03-29,2015-06-27,2016-08-03 14:09:58+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,60328000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2015.0,Q2,2015-03-29,2015-06-27,2016-08-03 14:09:58+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,11076000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2015.0,Q2,2015-03-29,2015-06-27,2016-08-03 14:09:58+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,49252000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2015.0,Q2,2015-03-29,2015-06-27,2016-08-03 14:09:58+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-7000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2015.0,Q2,2015-03-29,2015-06-27,2016-08-03 14:09:58+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,49245000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2015.0,Q2,2015-03-29,2015-06-27,2016-08-03 14:09:58+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,736000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2015.0,Q2,2015-03-29,2015-06-27,2016-08-03 14:09:58+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,48509000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2015.0,Q2,2015-03-29,2015-06-27,2016-08-03 14:09:58+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,46600000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2015.0,Q2,2015-03-29,2015-06-27,2016-08-03 14:09:58+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.04
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2015.0,Q2,2015-03-29,2015-06-27,2016-08-03 14:09:58+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,47600000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2015.0,Q2,2015-03-29,2015-06-27,2016-08-03 14:09:58+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.02
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2015.0,Q2,2015-03-29,2015-06-27,2016-08-03 14:09:58+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,46600000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2015.0,Q2,2015-03-29,2015-06-27,2016-08-03 14:09:58+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.04
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2015.0,Q3,2015-06-28,2015-09-26,2016-11-02 14:30:23+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,349465000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2015.0,Q3,2015-06-28,2015-09-26,2016-11-02 14:30:23+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,349465000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2015.0,Q3,2015-06-28,2015-09-26,2016-11-02 14:30:23+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,211390000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2015.0,Q3,2015-06-28,2015-09-26,2016-11-02 14:30:23+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,211390000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2015.0,Q3,2015-06-28,2015-09-26,2016-11-02 14:30:23+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,138075000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2015.0,Q3,2015-06-28,2015-09-26,2016-11-02 14:30:23+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,76225000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2015.0,Q3,2015-06-28,2015-09-26,2016-11-02 14:30:23+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,6410000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2015.0,Q3,2015-06-28,2015-09-26,2016-11-02 14:30:23+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,82635000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2015.0,Q3,2015-06-28,2015-09-26,2016-11-02 14:30:23+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,55440000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2015.0,Q3,2015-06-28,2015-09-26,2016-11-02 14:30:23+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3851000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2015.0,Q3,2015-06-28,2015-09-26,2016-11-02 14:30:23+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,177000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2015.0,Q3,2015-06-28,2015-09-26,2016-11-02 14:30:23+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1390000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2015.0,Q3,2015-06-28,2015-09-26,2016-11-02 14:30:23+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2284000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2015.0,Q3,2015-06-28,2015-09-26,2016-11-02 14:30:23+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,53156000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2015.0,Q3,2015-06-28,2015-09-26,2016-11-02 14:30:23+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,15255000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2015.0,Q3,2015-06-28,2015-09-26,2016-11-02 14:30:23+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,37901000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2015.0,Q3,2015-06-28,2015-09-26,2016-11-02 14:30:23+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-34000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2015.0,Q3,2015-06-28,2015-09-26,2016-11-02 14:30:23+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,37867000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2015.0,Q3,2015-06-28,2015-09-26,2016-11-02 14:30:23+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,488000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2015.0,Q3,2015-06-28,2015-09-26,2016-11-02 14:30:23+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,37379000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2015.0,Q3,2015-06-28,2015-09-26,2016-11-02 14:30:23+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,46100000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2015.0,Q3,2015-06-28,2015-09-26,2016-11-02 14:30:23+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.81
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2015.0,Q3,2015-06-28,2015-09-26,2016-11-02 14:30:23+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,47300000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2015.0,Q3,2015-06-28,2015-09-26,2016-11-02 14:30:23+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.79
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2015.0,Q3,2015-06-28,2015-09-26,2016-11-02 14:30:23+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,46100000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2015.0,Q3,2015-06-28,2015-09-26,2016-11-02 14:30:23+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.81
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2015.0,Q4,2015-09-27,2015-12-26,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,353850000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2015.0,Q4,2015-09-27,2015-12-26,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,353850000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2015.0,Q4,2015-09-27,2015-12-26,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,213276000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2015.0,Q4,2015-09-27,2015-12-26,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,213276000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2015.0,Q4,2015-09-27,2015-12-26,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,140574000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2015.0,Q4,2015-09-27,2015-12-26,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,81461000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2015.0,Q4,2015-09-27,2015-12-26,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,6844000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2015.0,Q4,2015-09-27,2015-12-26,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,88305000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2015.0,Q4,2015-09-27,2015-12-26,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,52269000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2015.0,Q4,2015-09-27,2015-12-26,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3821000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2015.0,Q4,2015-09-27,2015-12-26,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,285000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2015.0,Q4,2015-09-27,2015-12-26,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1259000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2015.0,Q4,2015-09-27,2015-12-26,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2277000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2015.0,Q4,2015-09-27,2015-12-26,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,49992000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2015.0,Q4,2015-09-27,2015-12-26,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,16729000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2015.0,Q4,2015-09-27,2015-12-26,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,33263000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2015.0,Q4,2015-09-27,2015-12-26,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-902000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2015.0,Q4,2015-09-27,2015-12-26,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,32361000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2015.0,Q4,2015-09-27,2015-12-26,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,477000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2015.0,Q4,2015-09-27,2015-12-26,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,31884000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2015.0,Q4,2015-09-27,2015-12-26,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,46500000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2015.0,Q4,2015-09-27,2015-12-26,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.69
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2015.0,Q4,2015-09-27,2015-12-26,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,47700000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2015.0,Q4,2015-09-27,2015-12-26,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.66
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2015.0,Q4,2015-09-27,2015-12-26,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,46500000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2015.0,Q4,2015-09-27,2015-12-26,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.69
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2016.0,Q1,2015-12-27,2016-03-26,2017-05-10 13:40:48+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,354868000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2016.0,Q1,2015-12-27,2016-03-26,2017-05-10 13:40:48+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,354868000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2016.0,Q1,2015-12-27,2016-03-26,2017-05-10 13:40:48+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,214100000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2016.0,Q1,2015-12-27,2016-03-26,2017-05-10 13:40:48+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,214100000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2016.0,Q1,2015-12-27,2016-03-26,2017-05-10 13:40:48+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,140768000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2016.0,Q1,2015-12-27,2016-03-26,2017-05-10 13:40:48+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,82944000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2016.0,Q1,2015-12-27,2016-03-26,2017-05-10 13:40:48+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,6352000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2016.0,Q1,2015-12-27,2016-03-26,2017-05-10 13:40:48+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,89296000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2016.0,Q1,2015-12-27,2016-03-26,2017-05-10 13:40:48+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,51472000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2016.0,Q1,2015-12-27,2016-03-26,2017-05-10 13:40:48+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4211000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2016.0,Q1,2015-12-27,2016-03-26,2017-05-10 13:40:48+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,263000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2016.0,Q1,2015-12-27,2016-03-26,2017-05-10 13:40:48+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,4026000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2016.0,Q1,2015-12-27,2016-03-26,2017-05-10 13:40:48+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,78000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2016.0,Q1,2015-12-27,2016-03-26,2017-05-10 13:40:48+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,51550000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2016.0,Q1,2015-12-27,2016-03-26,2017-05-10 13:40:48+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,13975000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2016.0,Q1,2015-12-27,2016-03-26,2017-05-10 13:40:48+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,37575000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2016.0,Q1,2015-12-27,2016-03-26,2017-05-10 13:40:48+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-26000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2016.0,Q1,2015-12-27,2016-03-26,2017-05-10 13:40:48+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,37549000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2016.0,Q1,2015-12-27,2016-03-26,2017-05-10 13:40:48+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,406000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2016.0,Q1,2015-12-27,2016-03-26,2017-05-10 13:40:48+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,37143000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2016.0,Q1,2015-12-27,2016-03-26,2017-05-10 13:40:48+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,46400000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2016.0,Q1,2015-12-27,2016-03-26,2017-05-10 13:40:48+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.8
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2016.0,Q1,2015-12-27,2016-03-26,2017-05-10 13:40:48+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,47600000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2016.0,Q1,2015-12-27,2016-03-26,2017-05-10 13:40:48+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.78
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2016.0,Q1,2015-12-27,2016-03-26,2017-05-10 13:40:48+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,46400000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2016.0,Q1,2015-12-27,2016-03-26,2017-05-10 13:40:48+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.8
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2016.0,Q2,2016-03-27,2016-06-25,2017-08-09 14:25:23+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,434055000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2016.0,Q2,2016-03-27,2016-06-25,2017-08-09 14:25:23+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,434055000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2016.0,Q2,2016-03-27,2016-06-25,2017-08-09 14:25:23+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,264308000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2016.0,Q2,2016-03-27,2016-06-25,2017-08-09 14:25:23+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,264308000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2016.0,Q2,2016-03-27,2016-06-25,2017-08-09 14:25:23+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,169747000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2016.0,Q2,2016-03-27,2016-06-25,2017-08-09 14:25:23+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,100473000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2016.0,Q2,2016-03-27,2016-06-25,2017-08-09 14:25:23+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,11213000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2016.0,Q2,2016-03-27,2016-06-25,2017-08-09 14:25:23+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,111686000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2016.0,Q2,2016-03-27,2016-06-25,2017-08-09 14:25:23+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,58061000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2016.0,Q2,2016-03-27,2016-06-25,2017-08-09 14:25:23+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,8909000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2016.0,Q2,2016-03-27,2016-06-25,2017-08-09 14:25:23+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,222000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2016.0,Q2,2016-03-27,2016-06-25,2017-08-09 14:25:23+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,5016000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2016.0,Q2,2016-03-27,2016-06-25,2017-08-09 14:25:23+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3671000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2016.0,Q2,2016-03-27,2016-06-25,2017-08-09 14:25:23+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,54390000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2016.0,Q2,2016-03-27,2016-06-25,2017-08-09 14:25:23+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,18845000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2016.0,Q2,2016-03-27,2016-06-25,2017-08-09 14:25:23+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,35545000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2016.0,Q2,2016-03-27,2016-06-25,2017-08-09 14:25:23+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,12000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2016.0,Q2,2016-03-27,2016-06-25,2017-08-09 14:25:23+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,35557000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2016.0,Q2,2016-03-27,2016-06-25,2017-08-09 14:25:23+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,350000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2016.0,Q2,2016-03-27,2016-06-25,2017-08-09 14:25:23+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,35207000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2016.0,Q2,2016-03-27,2016-06-25,2017-08-09 14:25:23+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,46900000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2016.0,Q2,2016-03-27,2016-06-25,2017-08-09 14:25:23+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.75
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2016.0,Q2,2016-03-27,2016-06-25,2017-08-09 14:25:23+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,48200000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2016.0,Q2,2016-03-27,2016-06-25,2017-08-09 14:25:23+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.73
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2016.0,Q2,2016-03-27,2016-06-25,2017-08-09 14:25:23+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,46900000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2016.0,Q2,2016-03-27,2016-06-25,2017-08-09 14:25:23+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.75
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2016.0,Q3,2016-06-26,2016-09-24,2017-11-09 10:07:34+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,425720000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2016.0,Q3,2016-06-26,2016-09-24,2017-11-09 10:07:34+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,425720000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2016.0,Q3,2016-06-26,2016-09-24,2017-11-09 10:07:34+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,269450000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2016.0,Q3,2016-06-26,2016-09-24,2017-11-09 10:07:34+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,269450000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2016.0,Q3,2016-06-26,2016-09-24,2017-11-09 10:07:34+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,156270000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2016.0,Q3,2016-06-26,2016-09-24,2017-11-09 10:07:34+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,85650000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2016.0,Q3,2016-06-26,2016-09-24,2017-11-09 10:07:34+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,11825000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2016.0,Q3,2016-06-26,2016-09-24,2017-11-09 10:07:34+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,97475000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2016.0,Q3,2016-06-26,2016-09-24,2017-11-09 10:07:34+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,58795000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2016.0,Q3,2016-06-26,2016-09-24,2017-11-09 10:07:34+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,7079000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2016.0,Q3,2016-06-26,2016-09-24,2017-11-09 10:07:34+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,523000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2016.0,Q3,2016-06-26,2016-09-24,2017-11-09 10:07:34+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1017000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2016.0,Q3,2016-06-26,2016-09-24,2017-11-09 10:07:34+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-5539000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2016.0,Q3,2016-06-26,2016-09-24,2017-11-09 10:07:34+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,53256000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2016.0,Q3,2016-06-26,2016-09-24,2017-11-09 10:07:34+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,15565000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2016.0,Q3,2016-06-26,2016-09-24,2017-11-09 10:07:34+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,37691000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2016.0,Q3,2016-06-26,2016-09-24,2017-11-09 10:07:34+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,342000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2016.0,Q3,2016-06-26,2016-09-24,2017-11-09 10:07:34+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,38033000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2016.0,Q3,2016-06-26,2016-09-24,2017-11-09 10:07:34+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,298000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2016.0,Q3,2016-06-26,2016-09-24,2017-11-09 10:07:34+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,37735000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2016.0,Q3,2016-06-26,2016-09-24,2017-11-09 10:07:34+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,47200000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2016.0,Q3,2016-06-26,2016-09-24,2017-11-09 10:07:34+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.8
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2016.0,Q3,2016-06-26,2016-09-24,2017-11-09 10:07:34+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,47800000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2016.0,Q3,2016-06-26,2016-09-24,2017-11-09 10:07:34+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.79
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2016.0,Q3,2016-06-26,2016-09-24,2017-11-09 10:07:34+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,47200000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2016.0,Q3,2016-06-26,2016-09-24,2017-11-09 10:07:34+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.8
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2016.0,Q4,2016-09-25,2016-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,466789000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2016.0,Q4,2016-09-25,2016-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,466789000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2016.0,Q4,2016-09-25,2016-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,289615000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2016.0,Q4,2016-09-25,2016-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,289615000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2016.0,Q4,2016-09-25,2016-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,177174000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2016.0,Q4,2016-09-25,2016-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,95641000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2016.0,Q4,2016-09-25,2016-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,12309000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2016.0,Q4,2016-09-25,2016-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,107950000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2016.0,Q4,2016-09-25,2016-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,69224000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2016.0,Q4,2016-09-25,2016-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,7510000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2016.0,Q4,2016-09-25,2016-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,306000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2016.0,Q4,2016-09-25,2016-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1705000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2016.0,Q4,2016-09-25,2016-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-5499000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2016.0,Q4,2016-09-25,2016-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,63725000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2016.0,Q4,2016-09-25,2016-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,18450000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2016.0,Q4,2016-09-25,2016-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,45275000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2016.0,Q4,2016-09-25,2016-12-31,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-48000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2016.0,Q4,2016-09-25,2016-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,45227000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2016.0,Q4,2016-09-25,2016-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,547000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2016.0,Q4,2016-09-25,2016-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,44680000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2016.0,Q4,2016-09-25,2016-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,47014000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2016.0,Q4,2016-09-25,2016-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.94
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2016.0,Q4,2016-09-25,2016-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,47958000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2016.0,Q4,2016-09-25,2016-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.93
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2016.0,Q4,2016-09-25,2016-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,47000000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2016.0,Q4,2016-09-25,2016-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.94
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2017.0,Q1,2017-01-01,2017-04-01,2018-05-10 15:53:23+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,445763000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2017.0,Q1,2017-01-01,2017-04-01,2018-05-10 15:53:23+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,445763000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2017.0,Q1,2017-01-01,2017-04-01,2018-05-10 15:53:23+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,274411000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2017.0,Q1,2017-01-01,2017-04-01,2018-05-10 15:53:23+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,274411000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2017.0,Q1,2017-01-01,2017-04-01,2018-05-10 15:53:23+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,171352000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2017.0,Q1,2017-01-01,2017-04-01,2018-05-10 15:53:23+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,90909000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2017.0,Q1,2017-01-01,2017-04-01,2018-05-10 15:53:23+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,10737000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2017.0,Q1,2017-01-01,2017-04-01,2018-05-10 15:53:23+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,101646000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2017.0,Q1,2017-01-01,2017-04-01,2018-05-10 15:53:23+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,69706000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2017.0,Q1,2017-01-01,2017-04-01,2018-05-10 15:53:23+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,6983000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2017.0,Q1,2017-01-01,2017-04-01,2018-05-10 15:53:23+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,202000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2017.0,Q1,2017-01-01,2017-04-01,2018-05-10 15:53:23+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,15122000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2017.0,Q1,2017-01-01,2017-04-01,2018-05-10 15:53:23+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,8341000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2017.0,Q1,2017-01-01,2017-04-01,2018-05-10 15:53:23+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,78047000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2017.0,Q1,2017-01-01,2017-04-01,2018-05-10 15:53:23+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,31084000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2017.0,Q1,2017-01-01,2017-04-01,2018-05-10 15:53:23+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,46963000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2017.0,Q1,2017-01-01,2017-04-01,2018-05-10 15:53:23+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-4000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2017.0,Q1,2017-01-01,2017-04-01,2018-05-10 15:53:23+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,46959000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2017.0,Q1,2017-01-01,2017-04-01,2018-05-10 15:53:23+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,181000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2017.0,Q1,2017-01-01,2017-04-01,2018-05-10 15:53:23+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,46778000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2017.0,Q1,2017-01-01,2017-04-01,2018-05-10 15:53:23+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,47700000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2017.0,Q1,2017-01-01,2017-04-01,2018-05-10 15:53:23+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.98
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2017.0,Q1,2017-01-01,2017-04-01,2018-05-10 15:53:23+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,48200000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2017.0,Q1,2017-01-01,2017-04-01,2018-05-10 15:53:23+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.97
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2017.0,Q1,2017-01-01,2017-04-01,2018-05-10 15:53:23+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,47700000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2017.0,Q1,2017-01-01,2017-04-01,2018-05-10 15:53:23+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.98
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2017.0,Q2,2017-04-02,2017-07-01,2018-08-08 16:37:30+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,469129000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2017.0,Q2,2017-04-02,2017-07-01,2018-08-08 16:37:30+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,469129000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2017.0,Q2,2017-04-02,2017-07-01,2018-08-08 16:37:30+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,283804000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2017.0,Q2,2017-04-02,2017-07-01,2018-08-08 16:37:30+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,283804000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2017.0,Q2,2017-04-02,2017-07-01,2018-08-08 16:37:30+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,185325000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2017.0,Q2,2017-04-02,2017-07-01,2018-08-08 16:37:30+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,93820000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2017.0,Q2,2017-04-02,2017-07-01,2018-08-08 16:37:30+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,9819000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2017.0,Q2,2017-04-02,2017-07-01,2018-08-08 16:37:30+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,103639000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2017.0,Q2,2017-04-02,2017-07-01,2018-08-08 16:37:30+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,81686000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2017.0,Q2,2017-04-02,2017-07-01,2018-08-08 16:37:30+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,7403000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2017.0,Q2,2017-04-02,2017-07-01,2018-08-08 16:37:30+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,161000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2017.0,Q2,2017-04-02,2017-07-01,2018-08-08 16:37:30+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,2472000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2017.0,Q2,2017-04-02,2017-07-01,2018-08-08 16:37:30+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4770000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2017.0,Q2,2017-04-02,2017-07-01,2018-08-08 16:37:30+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,76916000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2017.0,Q2,2017-04-02,2017-07-01,2018-08-08 16:37:30+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,22243000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2017.0,Q2,2017-04-02,2017-07-01,2018-08-08 16:37:30+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,54673000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2017.0,Q2,2017-04-02,2017-07-01,2018-08-08 16:37:30+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-71000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2017.0,Q2,2017-04-02,2017-07-01,2018-08-08 16:37:30+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,54602000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2017.0,Q2,2017-04-02,2017-07-01,2018-08-08 16:37:30+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,650000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2017.0,Q2,2017-04-02,2017-07-01,2018-08-08 16:37:30+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,53952000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2017.0,Q2,2017-04-02,2017-07-01,2018-08-08 16:37:30+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,47700000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2017.0,Q2,2017-04-02,2017-07-01,2018-08-08 16:37:30+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.13
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2017.0,Q2,2017-04-02,2017-07-01,2018-08-08 16:37:30+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,48200000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2017.0,Q2,2017-04-02,2017-07-01,2018-08-08 16:37:30+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.12
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2017.0,Q2,2017-04-02,2017-07-01,2018-08-08 16:37:30+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,47700000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2017.0,Q2,2017-04-02,2017-07-01,2018-08-08 16:37:30+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.13
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2018.0,Q1,2017-12-31,2018-03-31,2019-05-07 16:14:26+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,493970000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2018.0,Q1,2017-12-31,2018-03-31,2019-05-07 16:14:26+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,493970000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2018.0,Q1,2017-12-31,2018-03-31,2019-05-07 16:14:26+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,312501000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2018.0,Q1,2017-12-31,2018-03-31,2019-05-07 16:14:26+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,312501000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2018.0,Q1,2017-12-31,2018-03-31,2019-05-07 16:14:26+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,181469000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2018.0,Q1,2017-12-31,2018-03-31,2019-05-07 16:14:26+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,103372000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2018.0,Q1,2017-12-31,2018-03-31,2019-05-07 16:14:26+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,10268000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2018.0,Q1,2017-12-31,2018-03-31,2019-05-07 16:14:26+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,113640000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2018.0,Q1,2017-12-31,2018-03-31,2019-05-07 16:14:26+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,67829000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2018.0,Q1,2017-12-31,2018-03-31,2019-05-07 16:14:26+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,11191000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2018.0,Q1,2017-12-31,2018-03-31,2019-05-07 16:14:26+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,282000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2018.0,Q1,2017-12-31,2018-03-31,2019-05-07 16:14:26+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,6120000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2018.0,Q1,2017-12-31,2018-03-31,2019-05-07 16:14:26+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4789000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2018.0,Q1,2017-12-31,2018-03-31,2019-05-07 16:14:26+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,63040000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2018.0,Q1,2017-12-31,2018-03-31,2019-05-07 16:14:26+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,9772000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2018.0,Q1,2017-12-31,2018-03-31,2019-05-07 16:14:26+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,53268000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2018.0,Q1,2017-12-31,2018-03-31,2019-05-07 16:14:26+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-23000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2018.0,Q1,2017-12-31,2018-03-31,2019-05-07 16:14:26+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,53245000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2018.0,Q1,2017-12-31,2018-03-31,2019-05-07 16:14:26+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,614000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2018.0,Q1,2017-12-31,2018-03-31,2019-05-07 16:14:26+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,52631000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2018.0,Q1,2017-12-31,2018-03-31,2019-05-07 16:14:26+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,47785000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2018.0,Q1,2017-12-31,2018-03-31,2019-05-07 16:14:26+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.1
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2018.0,Q1,2017-12-31,2018-03-31,2019-05-07 16:14:26+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,48828000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2018.0,Q1,2017-12-31,2018-03-31,2019-05-07 16:14:26+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.08
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2018.0,Q1,2017-12-31,2018-03-31,2019-05-07 16:14:26+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,47800000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2018.0,Q1,2017-12-31,2018-03-31,2019-05-07 16:14:26+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.1
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2018.0,Q2,2018-04-01,2018-06-30,2019-07-31 14:54:51+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,585301000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2018.0,Q2,2018-04-01,2018-06-30,2019-07-31 14:54:51+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,585301000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2018.0,Q2,2018-04-01,2018-06-30,2019-07-31 14:54:51+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,369320000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2018.0,Q2,2018-04-01,2018-06-30,2019-07-31 14:54:51+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,369320000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2018.0,Q2,2018-04-01,2018-06-30,2019-07-31 14:54:51+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,215981000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2018.0,Q2,2018-04-01,2018-06-30,2019-07-31 14:54:51+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,120531000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2018.0,Q2,2018-04-01,2018-06-30,2019-07-31 14:54:51+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,18740000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2018.0,Q2,2018-04-01,2018-06-30,2019-07-31 14:54:51+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,139271000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2018.0,Q2,2018-04-01,2018-06-30,2019-07-31 14:54:51+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,76710000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2018.0,Q2,2018-04-01,2018-06-30,2019-07-31 14:54:51+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,18643000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2018.0,Q2,2018-04-01,2018-06-30,2019-07-31 14:54:51+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,182000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2018.0,Q2,2018-04-01,2018-06-30,2019-07-31 14:54:51+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,12039000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2018.0,Q2,2018-04-01,2018-06-30,2019-07-31 14:54:51+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-6422000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2018.0,Q2,2018-04-01,2018-06-30,2019-07-31 14:54:51+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,70288000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2018.0,Q2,2018-04-01,2018-06-30,2019-07-31 14:54:51+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,17438000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2018.0,Q2,2018-04-01,2018-06-30,2019-07-31 14:54:51+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,52850000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2018.0,Q2,2018-04-01,2018-06-30,2019-07-31 14:54:51+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,1529000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2018.0,Q2,2018-04-01,2018-06-30,2019-07-31 14:54:51+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,54379000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2018.0,Q2,2018-04-01,2018-06-30,2019-07-31 14:54:51+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,670000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2018.0,Q2,2018-04-01,2018-06-30,2019-07-31 14:54:51+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,53709000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2018.0,Q2,2018-04-01,2018-06-30,2019-07-31 14:54:51+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,48198000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2018.0,Q2,2018-04-01,2018-06-30,2019-07-31 14:54:51+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.11
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2018.0,Q2,2018-04-01,2018-06-30,2019-07-31 14:54:51+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,49043000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2018.0,Q2,2018-04-01,2018-06-30,2019-07-31 14:54:51+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.1
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2018.0,Q2,2018-04-01,2018-06-30,2019-07-31 14:54:51+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,48400000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2018.0,Q2,2018-04-01,2018-06-30,2019-07-31 14:54:51+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.11
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2018.0,Q3,2018-07-01,2018-09-29,2019-11-06 15:03:41+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,585295000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2018.0,Q3,2018-07-01,2018-09-29,2019-11-06 15:03:41+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,585295000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2018.0,Q3,2018-07-01,2018-09-29,2019-11-06 15:03:41+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,369095000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2018.0,Q3,2018-07-01,2018-09-29,2019-11-06 15:03:41+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,369095000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2018.0,Q3,2018-07-01,2018-09-29,2019-11-06 15:03:41+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,216200000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2018.0,Q3,2018-07-01,2018-09-29,2019-11-06 15:03:41+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,113033000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2018.0,Q3,2018-07-01,2018-09-29,2019-11-06 15:03:41+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,18805000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2018.0,Q3,2018-07-01,2018-09-29,2019-11-06 15:03:41+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,131838000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2018.0,Q3,2018-07-01,2018-09-29,2019-11-06 15:03:41+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,84362000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2018.0,Q3,2018-07-01,2018-09-29,2019-11-06 15:03:41+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,17197000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2018.0,Q3,2018-07-01,2018-09-29,2019-11-06 15:03:41+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,230000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2018.0,Q3,2018-07-01,2018-09-29,2019-11-06 15:03:41+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,5910000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2018.0,Q3,2018-07-01,2018-09-29,2019-11-06 15:03:41+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-11057000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2018.0,Q3,2018-07-01,2018-09-29,2019-11-06 15:03:41+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,73305000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2018.0,Q3,2018-07-01,2018-09-29,2019-11-06 15:03:41+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,12403000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2018.0,Q3,2018-07-01,2018-09-29,2019-11-06 15:03:41+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,60902000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2018.0,Q3,2018-07-01,2018-09-29,2019-11-06 15:03:41+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,0.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2018.0,Q3,2018-07-01,2018-09-29,2019-11-06 15:03:41+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,60902000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2018.0,Q3,2018-07-01,2018-09-29,2019-11-06 15:03:41+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,534000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2018.0,Q3,2018-07-01,2018-09-29,2019-11-06 15:03:41+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,60368000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2018.0,Q3,2018-07-01,2018-09-29,2019-11-06 15:03:41+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,48310000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2018.0,Q3,2018-07-01,2018-09-29,2019-11-06 15:03:41+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.25
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2018.0,Q3,2018-07-01,2018-09-29,2019-11-06 15:03:41+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,49326000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2018.0,Q3,2018-07-01,2018-09-29,2019-11-06 15:03:41+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.22
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2018.0,Q3,2018-07-01,2018-09-29,2019-11-06 15:03:41+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,48300000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2018.0,Q3,2018-07-01,2018-09-29,2019-11-06 15:03:41+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.25
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2018.0,Q4,2018-09-30,2018-12-29,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,601530000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2018.0,Q4,2018-09-30,2018-12-29,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,601530000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2018.0,Q4,2018-09-30,2018-12-29,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,375113000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2018.0,Q4,2018-09-30,2018-12-29,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,375113000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2018.0,Q4,2018-09-30,2018-12-29,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,226417000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2018.0,Q4,2018-09-30,2018-12-29,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,106918000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2018.0,Q4,2018-09-30,2018-12-29,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,17017000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2018.0,Q4,2018-09-30,2018-12-29,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,123935000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2018.0,Q4,2018-09-30,2018-12-29,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,102482000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2018.0,Q4,2018-09-30,2018-12-29,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,16741000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2018.0,Q4,2018-09-30,2018-12-29,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,118000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2018.0,Q4,2018-09-30,2018-12-29,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-10811000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2018.0,Q4,2018-09-30,2018-12-29,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-27434000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2018.0,Q4,2018-09-30,2018-12-29,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,75048000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2018.0,Q4,2018-09-30,2018-12-29,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,14850000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2018.0,Q4,2018-09-30,2018-12-29,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,60198000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2018.0,Q4,2018-09-30,2018-12-29,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,60198000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2018.0,Q4,2018-09-30,2018-12-29,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,533000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2018.0,Q4,2018-09-30,2018-12-29,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,59665000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2018.0,Q4,2018-09-30,2018-12-29,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,47947000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2018.0,Q4,2018-09-30,2018-12-29,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.26
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2018.0,Q4,2018-09-30,2018-12-29,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,49018000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2018.0,Q4,2018-09-30,2018-12-29,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.22
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2018.0,Q4,2018-09-30,2018-12-29,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,48000000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2018.0,Q4,2018-09-30,2018-12-29,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.26
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2019.0,Q1,2018-12-30,2019-03-30,2020-05-07 15:02:23+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,604569000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2019.0,Q1,2018-12-30,2019-03-30,2020-05-07 15:02:23+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,604569000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2019.0,Q1,2018-12-30,2019-03-30,2020-05-07 15:02:23+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,392792000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2019.0,Q1,2018-12-30,2019-03-30,2020-05-07 15:02:23+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,392792000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2019.0,Q1,2018-12-30,2019-03-30,2020-05-07 15:02:23+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,211777000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2019.0,Q1,2018-12-30,2019-03-30,2020-05-07 15:02:23+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,122574000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2019.0,Q1,2018-12-30,2019-03-30,2020-05-07 15:02:23+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,19411000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2019.0,Q1,2018-12-30,2019-03-30,2020-05-07 15:02:23+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,141985000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2019.0,Q1,2018-12-30,2019-03-30,2020-05-07 15:02:23+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,69792000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2019.0,Q1,2018-12-30,2019-03-30,2020-05-07 15:02:23+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,9987000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2019.0,Q1,2018-12-30,2019-03-30,2020-05-07 15:02:23+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,179000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2019.0,Q1,2018-12-30,2019-03-30,2020-05-07 15:02:23+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,6306000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2019.0,Q1,2018-12-30,2019-03-30,2020-05-07 15:02:23+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3502000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2019.0,Q1,2018-12-30,2019-03-30,2020-05-07 15:02:23+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,66290000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2019.0,Q1,2018-12-30,2019-03-30,2020-05-07 15:02:23+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,10602000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2019.0,Q1,2018-12-30,2019-03-30,2020-05-07 15:02:23+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,55688000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2019.0,Q1,2018-12-30,2019-03-30,2020-05-07 15:02:23+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,55688000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2019.0,Q1,2018-12-30,2019-03-30,2020-05-07 15:02:23+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,555000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2019.0,Q1,2018-12-30,2019-03-30,2020-05-07 15:02:23+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,55133000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2019.0,Q1,2018-12-30,2019-03-30,2020-05-07 15:02:23+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,48458000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2019.0,Q1,2018-12-30,2019-03-30,2020-05-07 15:02:23+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.14
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2019.0,Q1,2018-12-30,2019-03-30,2020-05-07 15:02:23+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,49462000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2019.0,Q1,2018-12-30,2019-03-30,2020-05-07 15:02:23+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.11
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2019.0,Q1,2018-12-30,2019-03-30,2020-05-07 15:02:23+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,48400000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2019.0,Q1,2018-12-30,2019-03-30,2020-05-07 15:02:23+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.14
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2019.0,Q2,2019-03-31,2019-06-29,2019-07-31 14:54:51+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,657568000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2019.0,Q2,2019-03-31,2019-06-29,2019-07-31 14:54:51+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,657568000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2019.0,Q2,2019-03-31,2019-06-29,2019-07-31 14:54:51+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,419464000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2019.0,Q2,2019-03-31,2019-06-29,2019-07-31 14:54:51+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,419464000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2019.0,Q2,2019-03-31,2019-06-29,2019-07-31 14:54:51+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,238104000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2019.0,Q2,2019-03-31,2019-06-29,2019-07-31 14:54:51+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,135941000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2019.0,Q2,2019-03-31,2019-06-29,2019-07-31 14:54:51+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,22395000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2019.0,Q2,2019-03-31,2019-06-29,2019-07-31 14:54:51+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,158336000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2019.0,Q2,2019-03-31,2019-06-29,2019-07-31 14:54:51+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,79768000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2019.0,Q2,2019-03-31,2019-06-29,2019-07-31 14:54:51+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,20835000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2019.0,Q2,2019-03-31,2019-06-29,2019-07-31 14:54:51+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,274000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2019.0,Q2,2019-03-31,2019-06-29,2019-07-31 14:54:51+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-213000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2019.0,Q2,2019-03-31,2019-06-29,2019-07-31 14:54:51+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-20774000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2019.0,Q2,2019-03-31,2019-06-29,2019-07-31 14:54:51+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,58994000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2019.0,Q2,2019-03-31,2019-06-29,2019-07-31 14:54:51+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,14685000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2019.0,Q2,2019-03-31,2019-06-29,2019-07-31 14:54:51+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,44309000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2019.0,Q2,2019-03-31,2019-06-29,2019-07-31 14:54:51+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,0.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2019.0,Q2,2019-03-31,2019-06-29,2019-07-31 14:54:51+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,44309000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2019.0,Q2,2019-03-31,2019-06-29,2019-07-31 14:54:51+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,581000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2019.0,Q2,2019-03-31,2019-06-29,2019-07-31 14:54:51+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,43728000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2019.0,Q2,2019-03-31,2019-06-29,2019-07-31 14:54:51+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,48772000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2019.0,Q2,2019-03-31,2019-06-29,2019-07-31 14:54:51+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.9
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2019.0,Q2,2019-03-31,2019-06-29,2019-07-31 14:54:51+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,49662000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2019.0,Q2,2019-03-31,2019-06-29,2019-07-31 14:54:51+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.88
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2019.0,Q2,2019-03-31,2019-06-29,2019-07-31 14:54:51+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,48600000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2019.0,Q2,2019-03-31,2019-06-29,2019-07-31 14:54:51+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.9
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2019.0,Q3,2019-06-30,2019-09-28,2019-11-06 15:03:41+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,667951000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2019.0,Q3,2019-06-30,2019-09-28,2019-11-06 15:03:41+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,667951000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2019.0,Q3,2019-06-30,2019-09-28,2019-11-06 15:03:41+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,421835000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2019.0,Q3,2019-06-30,2019-09-28,2019-11-06 15:03:41+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,421835000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2019.0,Q3,2019-06-30,2019-09-28,2019-11-06 15:03:41+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,246116000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2019.0,Q3,2019-06-30,2019-09-28,2019-11-06 15:03:41+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,129509000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2019.0,Q3,2019-06-30,2019-09-28,2019-11-06 15:03:41+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,23805000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2019.0,Q3,2019-06-30,2019-09-28,2019-11-06 15:03:41+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,153314000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2019.0,Q3,2019-06-30,2019-09-28,2019-11-06 15:03:41+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,92802000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2019.0,Q3,2019-06-30,2019-09-28,2019-11-06 15:03:41+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,5698000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2019.0,Q3,2019-06-30,2019-09-28,2019-11-06 15:03:41+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,385000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2019.0,Q3,2019-06-30,2019-09-28,2019-11-06 15:03:41+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-14254000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2019.0,Q3,2019-06-30,2019-09-28,2019-11-06 15:03:41+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-19567000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2019.0,Q3,2019-06-30,2019-09-28,2019-11-06 15:03:41+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,73235000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2019.0,Q3,2019-06-30,2019-09-28,2019-11-06 15:03:41+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-317000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2019.0,Q3,2019-06-30,2019-09-28,2019-11-06 15:03:41+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,73552000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2019.0,Q3,2019-06-30,2019-09-28,2019-11-06 15:03:41+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,0.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2019.0,Q3,2019-06-30,2019-09-28,2019-11-06 15:03:41+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,73552000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2019.0,Q3,2019-06-30,2019-09-28,2019-11-06 15:03:41+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,742000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2019.0,Q3,2019-06-30,2019-09-28,2019-11-06 15:03:41+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,72810000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2019.0,Q3,2019-06-30,2019-09-28,2019-11-06 15:03:41+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,48818000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2019.0,Q3,2019-06-30,2019-09-28,2019-11-06 15:03:41+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.49
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2019.0,Q3,2019-06-30,2019-09-28,2019-11-06 15:03:41+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,49715000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2019.0,Q3,2019-06-30,2019-09-28,2019-11-06 15:03:41+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.46
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2019.0,Q3,2019-06-30,2019-09-28,2019-11-06 15:03:41+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,48900000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2019.0,Q3,2019-06-30,2019-09-28,2019-11-06 15:03:41+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.49
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2019.0,Q4,2019-09-29,2019-12-28,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,691138000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2019.0,Q4,2019-09-29,2019-12-28,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,691138000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2019.0,Q4,2019-09-29,2019-12-28,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,428824000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2019.0,Q4,2019-09-29,2019-12-28,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,428824000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2019.0,Q4,2019-09-29,2019-12-28,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,262314000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2019.0,Q4,2019-09-29,2019-12-28,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,129598000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2019.0,Q4,2019-09-29,2019-12-28,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,23927000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2019.0,Q4,2019-09-29,2019-12-28,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,153525000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2019.0,Q4,2019-09-29,2019-12-28,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,108789000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2019.0,Q4,2019-09-29,2019-12-28,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,24362000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2019.0,Q4,2019-09-29,2019-12-28,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,684000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2019.0,Q4,2019-09-29,2019-12-28,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,20454000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2019.0,Q4,2019-09-29,2019-12-28,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3224000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2019.0,Q4,2019-09-29,2019-12-28,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,105565000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2019.0,Q4,2019-09-29,2019-12-28,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,25053000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2019.0,Q4,2019-09-29,2019-12-28,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,80512000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2019.0,Q4,2019-09-29,2019-12-28,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,80512000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2019.0,Q4,2019-09-29,2019-12-28,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,164000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2019.0,Q4,2019-09-29,2019-12-28,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,80348000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2019.0,Q4,2019-09-29,2019-12-28,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,48730000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2019.0,Q4,2019-09-29,2019-12-28,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.64
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2019.0,Q4,2019-09-29,2019-12-28,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,49693000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2019.0,Q4,2019-09-29,2019-12-28,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.62
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2019.0,Q4,2019-09-29,2019-12-28,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,48700000.0
Charles River Laboratories International Inc,CRL,549300BSQ0R4UZ5KX287,0001100682,2019.0,Q4,2019-09-29,2019-12-28,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.64
